Mutya Harsch J.D.
Net Worth

Last updated:

What is Mutya Harsch J.D. net worth?

The estimated net worth of Ms. Mutya Harsch J.D. is at least $1,054,261 as of 20 Mar 2023. She owns shares worth $7,741 as insider and has received compensation worth at least $1,046,520 in VYNE Therapeutics Inc..

What is the salary of Mutya Harsch J.D.?

Ms. Mutya Harsch J.D. salary is $523,260 per year as Gen. Counsel, Chief Legal Officer & Company Sec. in VYNE Therapeutics Inc..

How old is Mutya Harsch J.D.?

Ms. Mutya Harsch J.D. is 50 years old, born in 1975.

What stocks does Mutya Harsch J.D. currently own?

As insider, Ms. Mutya Harsch J.D. owns shares in one company:

Company Title Shares Price per share Total value
VYNE Therapeutics Inc. (VYNE) Gen. Counsel, Chief Legal Officer & Company Sec. 22,721 $0.34 $7,741

What does VYNE Therapeutics Inc. do?

VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is also developing VYN201, a bromodomain and extra-terminal (BET) inhibitor for various immuno-inflammatory diseases, including skin diseases; and VYN202, BET inhibitor compounds that are selective for bromodomain 2. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.

Mutya Harsch J.D. insider trading

VYNE Therapeutics Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 10,000 $2.5 $25,000

VYNE Therapeutics key executives

VYNE Therapeutics Inc. executives and other stock owners filed with the SEC: